AEURX
Price
$8.89
Change
+$0.06 (+0.68%)
Updated
Jun 2 closing price
Net Assets
6.35B
VIVIX
Price
$83.17
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

AEURX vs VIVIX

Header iconAEURX vs VIVIX Comparison
Open Charts AEURX vs VIVIXBanner chart's image
AEURX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
AEURX vs. VIVIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEURX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 238B vs. AEURX (6.35B). VIVIX pays higher dividends than AEURX: VIVIX (1.87) vs AEURX (1.65). AEURX was incepted earlier than VIVIX: AEURX (23 years) vs VIVIX (28 years). AEURX (1.44) is less costly to investors than VIVIX (0.03). AEURX is a more actively managed with annual turnover of: 31.00 vs. VIVIX (8.00). AEURX has a lower initial minimum investment than VIVIX: AEURX (2500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 23.24 vs. AEURX (5.89). VIVIX return over 5 years is better than : 50.71 vs. AEURX (-2.47).
AEURXVIVIXAEURX / VIVIX
Total Expense Ratio1.440.034,800%
Annual Report Gross Expense Ratio1.440.034,800%
Fund Existence23 years28 years-
Gain YTD5.36410.67050%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.35B238B3%
Annual Yield % from dividends1.651.8788%
Returns for 1 year5.8923.2425%
Returns for 3 years7.0653.1813%
Returns for 5 years-2.4750.71-5%
Returns for 10 years19.74150.4213%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNBR1.260.02
+1.61%
Sleep Number Corp
GVA136.750.22
+0.16%
Granite Construction
SBUX95.51-1.00
-1.04%
Starbucks Corp
NEO10.12-0.32
-3.07%
NeoGenomics
AVXL2.78-0.20
-6.71%
Anavex Life Sciences Corp